Vitamin C (ascorbic acid) for myelodysplastic syndromes

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 24 Sep 2018: Trial registered, NCT03682029

The trials

NCT03682029: Epigenetics, Vitamin C, and Abnormal Blood Cell Formation - Vitamin C in Patients With Low-Risk Myeloid Malignancies

State
State not given
Phase
No phase
People
109 taking part
Started
21 Nov 2017
Primary completion
27 Sep 2023
Arms
Vitamin C
Results
None posted
  1. 21 Nov 2017: Trial started
  2. 24 Sep 2018: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

About the treatment

Kind of treatment: Diet or lifestyle.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.